Alterity Therapeutics (ATHE) Stock Chart & Stock Price History $3.50 +0.10 (+2.94%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$3.50 0.00 (-0.14%) As of 04/17/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alterity Therapeutics Stock Price Performance 5 Day Performance+9.03%1 Month Performance-11.84%3 Month Performance+2.34%6 Month Performance+177.78%Year-To-Date Performance+5.74%1 Year Performance+71.57% Receive ATHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ATHE Stock Chart for Saturday, April, 19, 2025 ATHE Chart by TradingView Alterity Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$3.50$3.50$3.50$3.319,069 shs$31.03 million04/17/2025$3.40$3.50+2.94%$3.50$3.319,069 shs$31.03 million04/16/2025$3.30$3.40+3.03%$3.41$3.109,552 shs$30.15 million04/15/2025$3.21$3.30+2.80%$3.30$3.116,133 shs$29.26 million04/14/2025$3.13$3.21+2.56%$3.21$3.099,679 shs$28.46 million04/11/2025$2.86$3.13+9.44%$3.14$2.8812,846 shs$27.75 million04/10/2025$2.76$2.86+3.62%$2.99$2.7620,022 shs$25.36 million04/09/2025$2.54$2.76+8.66%$2.90$2.5224,123 shs$24.47 million04/09/2025$2.54$2.76+8.66%$2.90$2.5224,123 shs$24.47 million04/08/2025$2.76$2.54-7.97%$2.69$2.5436,478 shs$22.52 million Get the Latest News and Ratings for ATHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$2.76$2.54-7.97%$2.69$2.5436,478 shs$22.52 million04/07/2025$2.88$2.76-4.20%$2.80$2.5732,350 shs$24.47 million04/04/2025$2.93$2.88-1.67%$3.02$2.5852,922 shs$25.55 million04/03/2025$3.10$2.93-5.48%$3.05$2.8724,181 shs$25.98 million04/02/2025$3.18$3.10-2.52%$3.20$3.038,463 shs$27.49 million04/01/2025$3.39$3.18-6.22%$3.38$3.1434,985 shs$28.20 million03/31/2025$3.44$3.39-1.42%$3.49$3.408,855 shs$30.07 million03/28/2025$3.56$3.44-3.37%$3.58$3.4112,318 shs$30.50 million03/27/2025$3.56$3.56$3.56$3.4510,843 shs$31.57 million03/26/2025$3.58$3.56-0.42%$3.63$3.544,962 shs$31.57 million03/25/2025$3.54$3.58+0.99%$3.72$3.524,098 shs$31.70 million03/24/2025$3.77$3.54-6.10%$3.81$3.5240,014 shs$31.39 million03/21/2025$3.92$3.77-3.83%$3.98$3.6932,782 shs$33.43 million03/20/2025$3.97$3.92-1.26%$3.95$3.795,187 shs$34.76 million03/19/2025$3.83$3.97+3.66%$3.98$3.727,629 shs$35.20 million03/18/2025$4.03$3.83-4.96%$3.98$3.668,825 shs$33.96 million Related Companies CHRS Stock Chart FTLF Stock Chart EPRX Stock Chart EDIT Stock Chart NMRA Stock Chart TIL Stock Chart PROC Stock Chart FATE Stock Chart ENTA Stock Chart TNXP Stock Chart Receive ATHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATHE) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Alterity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.